Project Grant K01DK139458
- The federal Project Grant award of $731,071 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to address the challenges preventing the provision of guideline-recommended diabetes care in the United States. The overarching goals are to: Describe differences in diabetes care receipt across individual, neighborhood, and insurance characteristics. Examine differences in...
- This federal Project Grant award of $779,978 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to identify optimal supportive components and adaptive treatment sequences for improving diabetes outcomes and addressing unmet social needs among individuals with high HbA1c levels. The overarching goal is to conduct a 12-month Sequential Multiple Assignment Randomized Trial (SMART) to evaluate...
- This $1,089,491 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to develop novel statistical methods, computational algorithms, and user-friendly software to study individual health trajectories relevant to disease onset and progression for large, diverse healthcare datasets like electronic medical records and biobanks. The research, to be conducted by the University of...
- This federal Project Grant award of $147,459 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to address racial and ethnic disparities in diabetes risk after varying glycemia levels during pregnancy. The key focus of the project is to investigate if future diabetes risk after gestational diabetes mellitus (GDM) and gestational glucose intolerance (GGI)...
- This $192,215 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program) will support a research project titled "Assessing Patient-Centric Factors and Enhancing Risk Communication to Improve Treatment Persistence in Kidney and Cardiovascular Care" at the University of California, San Francisco (UCSF). The project aims to develop an effective risk communication aid to...
- This Project Grant award of $248,915 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to unravel the role of epigenetics and cytokines in type 2 diabetes among African-ancestry populations in the U.S. and Europe. The research aims to identify causal associations between DNA methylation, circulating cytokines, and diabetes risk in these populations...
- This $161,664 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to develop "DREAM: BUILDING EQUITABLE PREDICTIVE MODELS FOR PERSONALIZED DIABETES PHARMACOTHERAPY." The project has three key objectives: (1) creating predictive models to estimate individualized outcomes like HbA1c, weight, and hypoglycemia for diabetes medication options,...
- The federal Project Grant award of $843,485 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will support Duke University's evaluation of two novel, population-tailored health insurance designs and their impact on diabetes outcomes among working-age adults. The project aims to assess 10-year trends in the adoption of population-tailored insurance plans that provide more generous benefits to...
- This federal Project Grant award of $232,875.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The objective of this 2-year project is to conduct a mixed methods study characterizing clinician communication practices around glycemic management for people with diabetes, with the goal of identifying and quantifying the most effective communication...
- The University of Chicago was awarded a $249,000 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research program) with a project period from May 1, 2025 to April 30, 2028. The grant will fund research to characterize the m6A methylome of aging B-cells and identify m6A-regulated pathways underlying accelerated B-cell senescence in diabetes. The overarching goal is to determine if m6A is a...
This $147,747 Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant aims to elucidate the pathways from socioeconomic status (SES) to glycemic control and the onset of diabetes complications, with a focus on understanding how treatment intensification patterns mediate this relationship. The research plan includes: 1) summarizing diverse treatment intensification patterns and medication usage across SES indicators using electronic health records, 2) assessing the impact of treatment intensification on the association between SES and diabetes outcomes, and 3) testing the predictive capabilities of SES, treatment intensification, and glucose levels in relation to early onset of diabetes complications using machine learning. This 5-year grant, which begins on September 15, 2025, will be performed by the University of Illinois in Chicago.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $147.7k | 9/12/25 |